ImmunityBio, Inc. (IBRX)
6.92
+0.44
(+6.79%)
USD |
NASDAQ |
Jan 21, 16:00
7.11
+0.19
(+2.75%)
Pre-Market: 08:42
ImmunityBio Total Liabilities (Quarterly): 1.042B for Sept. 30, 2025
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arbutus Biopharma Corp. | 20.31M |
| Aveanna Healthcare Holdings, Inc. | 1.801B |
| Corcept Therapeutics, Inc. | 191.70M |
| Cytokinetics, Inc. | 1.958B |
| Altimmune, Inc. | 32.85M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 518.99M |
| Shareholders Equity (Quarterly) | -524.32M |
| Debt to Equity Ratio | -1.643 |
| Current Ratio | 5.767 |
| Net Debt Paydown Yield | 1.14% |